Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases i…
$1.38-8.61%
报价 2026-11-10
市值
$6.1M
EV
$2.4M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -51.7%
$1.38$2.86
筛选结果
pipeline · 2026-11-10Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| KPRXKiora Pharmaceuticals, Inc. | $6.1M | -8.6% | 0.0% | 0% | – | – | – | |
| BCDABioCardia, Inc. | $14.1M | +3.1% | 0.0% | 0% | – | – | – | |
| PHIOPhio Pharmaceuticals Corp. | $9.5M | -3.1% | -100.0% | 0% | – | – | – | |
| INABIN8bio, Inc. | $9.5M | +2.0% | +418.5% | 0% | – | – | – | |
| ACXPAcurx Pharmaceuticals, Inc. | $5.8M | -1.9% | -97.1% | 0% | – | – | – | |
| APREAprea Therapeutics, Inc. | $5.6M | -11.1% | +266.7% | 0% | – | – | – | |
| APVOAptevo Therapeutics Inc. | $2.4M | -4.4% | +141.9% | 0% | – | – | – | |
| CELZCreative Medical Technology Holdings, Inc. | $1.6M | -1.8% | +779900.0% | -1,732.4% | – | – | – | |
| RNAZTransCode Therapeutics, Inc. | $1.4M | -12.3% | -50.0% | 0% | – | – | – | |
| 同行中位数 | – | – | +71.0% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。